NextCure Inc.

The momentum for this stock is not very good. NextCure Inc. is not a good value stock. NextCure Inc. is not a good growth stock. NextCure Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in NextCure Inc..

News

NextCure, Inc. (NASDAQ:NXTC) Shares Sold by Assenagon Asset Management S.A.

Ticker Report Assenagon Asset Management S.A. lowered its holdings in NextCure, Inc. (NASDAQ:NXTC - Free Report) by 56.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund...\n more…

NXTC Stock Earnings: NextCure Misses EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nNXTC stock results show that NextCure missed analyst estimates for earnings per share the second quarter of 2024.\nThe post NXTC Stock...\n more…

NextCure reports Q2 EPS (55c), consensus (38c)

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results

Globe Newswire LNCB74 (B7-H4 ADC) GLP tox studies completed and targeting an IND application by year-endNC410 combo with pembrolizumab ovarian cohort enrollment completedCash of approximately $86.4 million expected...\n more…

Short Interest in NextCure, Inc. (NASDAQ:NXTC) Drops By 15.0%

Ticker Report NextCure, Inc. (NASDAQ:NXTC - Get Free Report) saw a significant decline in short interest during the month of July. As of July 15th, there was short interest totalling 84,100 shares, a decline of...\n more…

NextCure (NASDAQ:NXTC) Trading Down 3.6%

Zolmax NextCure, Inc. (NASDAQ:NXTC - Get Free Report) shares were down 3.6% during trading on Monday . The company traded as low as $1.57 and last traded at $1.63. Approximately 60,815 shares traded hands...\n more…